We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$368M
2
CSCO icon
Cisco
CSCO
+$131M
3
WMT icon
Walmart Inc
WMT
+$109M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$93.1M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$87.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$124M
2
PX
Praxair Inc
PX
+$110M
3
KHC icon
Kraft Heinz
KHC
+$86.3M
4
XNTK icon
State Street SPDR NYSE Technology ETF
XNTK
+$67.4M
5
PSA icon
Public Storage
PSA
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMR icon
3276
Immersion
IMMR
$257M
$106K ﹤0.01%
11,775
– –
TCRT icon
3277
Alaunos Therapeutics
TCRT
$4.84M
$105K ﹤0.01%
375
-12
-3% -$4.74K
INO icon
3278
Inovio Pharmaceuticals
INO
$76.1M
$102K ﹤0.01%
2,116
+1,165
+123% +$70.8K
ATRS
3279
DELISTED
Antares Pharma, Inc.
ATRS
$102K ﹤0.01%
+37,449
New +$123K
ESV
3280
DELISTED
Ensco Rowan plc
ESV
$102K ﹤0.01%
7,153
-2,640
-27% -$68K
EXEL icon
3281
CALL
Exelixis
EXEL
$13.1B
$101K ﹤0.01%
28,800
-700
-2% -$12.5K
FOMX
3282
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$100K ﹤0.01%
27,900
-9,600
-26% -$41.7K
CRD.B icon
3283
Crawford & Co Class B
CRD.B
$588M
$99K ﹤0.01%
11,012
– –
NNY icon
3284
Nuveen New York Municipal Value Fund
NNY
$156M
$99K ﹤0.01%
10,324
-9,781
-49% -$90K
HLX icon
3285
Helix Energy Solutions
HLX
$1.47B
$98K ﹤0.01%
18,150
+5,194
+40% +$42.3K
IWM icon
3286
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$98K ﹤0.01%
+19,800
New +$2.95M
SNDX icon
3287
Syndax Pharmaceuticals
SNDX
$1.82B
$98K ﹤0.01%
+22,000
New +$121K
STON
3288
DELISTED
StoneMor Inc.
STON
$98K ﹤0.01%
46,779
-34,273
-42% -$139K
VRAY
3289
DELISTED
ViewRay, Inc.
VRAY
$96K ﹤0.01%
15,800
-6,000
-28% -$45K
AXU
3290
DELISTED
Alexco Resource Corp
AXU
$96K ﹤0.01%
103,677
-740
-0.7% -$667
WIN
3291
DELISTED
Windstream Holdings Inc
WIN
$96K ﹤0.01%
46,015
+1,527
+3% +$5.69K
GORO icon
3292
Goldgroup Mining Inc.
GORO
$186M
$94K ﹤0.01%
23,456
+3,401
+17% +$15.3K
CSLT
3293
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$94K ﹤0.01%
43,485
-10,015
-19% -$24.8K
BEDU
3294
DELISTED
Bright Scholar Education Holdings
BEDU
$93K ﹤0.01%
2,530
-1,020
-29% -$44.3K
CRD.A icon
3295
Crawford & Co Class A
CRD.A
$642M
$93K ﹤0.01%
10,412
-1,034
-9% -$9.3K
CRWS icon
3296
Crown Crafts
CRWS
$32M
$93K ﹤0.01%
17,300
-3,000
-15% -$16.7K
HL icon
3297
Hecla Mining
HL
$11.8B
$91K ﹤0.01%
38,519
+4,762
+14% +$12.2K
WVVI icon
3298
Willamette Valley Vineyards
WVVI
$11.7M
$89K ﹤0.01%
12,975
– –
AGFS
3299
DELISTED
AgroFresh Solutions Inc
AGFS
$88K ﹤0.01%
+23,100
New +$115K
CNR
3300
DELISTED
Cornerstone Building Brands, Inc.
CNR
$88K ﹤0.01%
12,156
-458
-4% -$5.49K
130 131
132
133 134

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.